STTR Phase 2: Commercialization of a Novel Therapeutic for Alzheimer's Disease

Grants and Contracts Details

StatusFinished
Effective start/end date11/1/175/31/20

Funding

  • CoPlex Therapeutics LLC: $553,051.00